COVID-19 in hospitalised patients in Spain: a cohort study in Madrid
Carmen Guadalupe Rodriguez-Gonzalez, Esther Chamorro-De-Vega, Maricela Valerio, Miguel Angel Amor-Garcia, Francisco Tejerina, Milagros Sancho-Gonzalez, Alvaro Narrillos-Moraza, Alvaro Gimenez-Manzorro, Silvia Manrique-Rodriguez, Marina Machado, Maria Olmedo, Vicente Escudero-Vilaplana, Cristina Villanueva-Bueno, Beatriz Torroba-Sanz, Alejandra Melgarejo-Ortuño, Juan Vicente-Valor, Ana Herranz, Emilio Bouza, Patricia Muñoz, Maria Sanjurjo
International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.106249
Few large series describe the clinical characteristics, outcomes and costs of COVID-19 in Western countries. This cohort reports the first 1255 adult cases receiving anti-COVID-19 treatment at a Spanish hospital (1-24 March 2020). Treatment costs were calculated. A logistic regression model was used to explore risk factors on admission associated with ARDS. A bivariate Cox proportional hazard ratio (HR) model was employed to determine the HR between individual factors and death. We included 1255 patients (median age 65 years; 57.8% male), of which 92.3% required hospitalisation. The prevalence of hypertension, cardiovascular disease and diabetes mellitus (DM) was 45.1%, 31.4% and 19.9%, respectively. Lymphocytopenia (54.8%), elevated alanine aminotransferase (33.0%) and elevated lactate dehydrogenase (58.5%) were frequent. Overall, 36.7% of patients developed ARDS, 10.0% were admitted to an ICU and 21.3% died. The most frequent antiviral combinations were lopinavir/ritonavir plus hydroxychloroquine (44.2%), followed by triple therapy with interferon beta-1b (32.7%). Corticosteroids and tocilizumab were used in 25.3% and 12.9% of patients, respectively. Total cost of anti-COVID-19 agents was €511 825 ( €408/patient). By multivariate analysis, risk factors associated with ARDS included older age, obesity, DM, severe hypoxaemia, lymphocytopenia, increased creatine kinase and increased C-reactive protein. In multivariate Cox model, older age (HR 1.07, 95% CI 1.06-1.09), cardiovascular disease (HR 1.34, 95% CI 1.01-1.79), DM (HR 1.45, 95% CI 1.09-1.92), severe hypoxaemia (HR 2.01, 95% CI 1.49-2.72), lymphocytopenia (HR 1.62, 95% CI 1.20-2.20) and increased C-reactive protein (HR 1.04, 95% CI 1.02-1.06) were risk factors for mortality.
Supplementary materials Supplementary material associated with this article can be found, in the online version, at doi: 10.1016/j.ijantimicag.2020. 106249 .
References
Armstrong, Kane, Cook, Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies, Anaesthesia,
doi:10.1111/anae.15201Cao, Wang, Wen, Liu, Wang et al., A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19, N Engl J Med,
doi:10.1056/NEJMoa2001282Docherty, Harrison, Green, Hardwick, Pius et al., Features of 20 133 UK patients in hospital with COVID-19 using the IS-ARIC WHO Clinical Characterisation Protocol: prospective observational cohort study, BMJ,
doi:10.1136/bmj.m1985Giacomelli, Ridolfo, Milazzo, Oreni, Bernacchia et al., 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study, Pharmacol Res,
doi:10.1016/j.phrs.2020.104931Grasselli, Zangrillo, Zanella, Antonelli, Cabrini et al., Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region. Italy, JAMA,
doi:10.1001/jama.2020.5394Guan, Ni, Hu, Liang, Ou et al., Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med,
doi:10.1056/NEJMoa2002032Richardson, Hirsch, Narasimhan, Crawford, Mcginn et al., Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area, JAMA,
doi:10.1001/jama.2020.6775Wu, Chen, Cai, Xia, Zhou et al., Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med,
doi:10.1001/jamainternmed.2020.0994DOI record:
{
"DOI": "10.1016/j.ijantimicag.2020.106249",
"ISSN": [
"0924-8579"
],
"URL": "http://dx.doi.org/10.1016/j.ijantimicag.2020.106249",
"alternative-id": [
"S0924857920304696"
],
"article-number": "106249",
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "COVID-19 in hospitalised patients in Spain: a cohort study in Madrid"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "International Journal of Antimicrobial Agents"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.ijantimicag.2020.106249"
},
{
"label": "Content Type",
"name": "content_type",
"value": "article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2020 Published by Elsevier Ltd."
}
],
"author": [
{
"ORCID": "http://orcid.org/0000-0003-1046-8830",
"affiliation": [],
"authenticated-orcid": false,
"family": "Rodriguez-Gonzalez",
"given": "Carmen Guadalupe",
"sequence": "first"
},
{
"affiliation": [],
"family": "Chamorro-de-Vega",
"given": "Esther",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Valerio",
"given": "Maricela",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Amor-Garcia",
"given": "Miguel Angel",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Tejerina",
"given": "Francisco",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Sancho-Gonzalez",
"given": "Milagros",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Narrillos-Moraza",
"given": "Alvaro",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Gimenez-Manzorro",
"given": "Alvaro",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Manrique-Rodriguez",
"given": "Silvia",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Machado",
"given": "Marina",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Olmedo",
"given": "Maria",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Escudero-Vilaplana",
"given": "Vicente",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Villanueva-Bueno",
"given": "Cristina",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Torroba-Sanz",
"given": "Beatriz",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Melgarejo-Ortuño",
"given": "Alejandra",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Vicente-Valor",
"given": "Juan",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Herranz",
"given": "Ana",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Bouza",
"given": "Emilio",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Muñoz",
"given": "Patricia",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Sanjurjo",
"given": "Maria",
"sequence": "additional"
}
],
"container-title": "International Journal of Antimicrobial Agents",
"container-title-short": "International Journal of Antimicrobial Agents",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"clinicalkey.jp",
"clinicalkey.com",
"clinicalkey.es",
"clinicalkey.com.au",
"clinicalkey.fr",
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2020,
11,
28
]
],
"date-time": "2020-11-28T16:15:45Z",
"timestamp": 1606580145000
},
"deposited": {
"date-parts": [
[
2021,
1,
26
]
],
"date-time": "2021-01-26T04:02:35Z",
"timestamp": 1611633755000
},
"indexed": {
"date-parts": [
[
2024,
3,
30
]
],
"date-time": "2024-03-30T16:28:11Z",
"timestamp": 1711816091268
},
"is-referenced-by-count": 26,
"issue": "2",
"issued": {
"date-parts": [
[
2021,
2
]
]
},
"journal-issue": {
"issue": "2",
"published-print": {
"date-parts": [
[
2021,
2
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
2,
1
]
],
"date-time": "2021-02-01T00:00:00Z",
"timestamp": 1612137600000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S0924857920304696?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S0924857920304696?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "106249",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2021,
2
]
]
},
"published-print": {
"date-parts": [
[
2021,
2
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.1016/j.phrs.2020.104931",
"article-title": "30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study",
"author": "Giacomelli",
"doi-asserted-by": "crossref",
"journal-title": "Pharmacol Res",
"key": "10.1016/j.ijantimicag.2020.106249_bib0001",
"volume": "158",
"year": "2020"
},
{
"DOI": "10.1001/jama.2020.6775",
"article-title": "Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area",
"author": "Richardson",
"doi-asserted-by": "crossref",
"first-page": "2052",
"journal-title": "JAMA",
"key": "10.1016/j.ijantimicag.2020.106249_bib0002",
"volume": "323",
"year": "2020"
},
{
"DOI": "10.1136/bmj.m1985",
"article-title": "Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study",
"author": "Docherty",
"doi-asserted-by": "crossref",
"first-page": "m1985",
"journal-title": "BMJ",
"key": "10.1016/j.ijantimicag.2020.106249_bib0003",
"volume": "369",
"year": "2020"
},
{
"key": "10.1016/j.ijantimicag.2020.106249_bib0004",
"series-title": "Clinical management of COVID-19: interim guidance",
"year": "2020"
},
{
"key": "10.1016/j.ijantimicag.2020.106249_bib0005",
"unstructured": "Real Decreto-ley 8/2010, de 20 de mayo, por el que se adoptan medidas extraordinarias para la reducción del déficit público. Boletín Oficial del Estado, n° 126 (24/05/2010)."
},
{
"DOI": "10.1001/jamainternmed.2020.0994",
"article-title": "Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China",
"author": "Wu",
"doi-asserted-by": "crossref",
"first-page": "934",
"journal-title": "JAMA Intern Med",
"key": "10.1016/j.ijantimicag.2020.106249_bib0006",
"volume": "180",
"year": "2020"
},
{
"key": "10.1016/j.ijantimicag.2020.106249_bib0007",
"unstructured": "Ministerio de Sanidad. Gobierno de España: Centro de Coordinación de Alertas y Emergencias Sanitarias. Informe Actualización n° 55. Enfermedad por el coronavirus (COVID-19).https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Actualizacion_55_COVID-19.pdf [accessed 3 December 2020]."
},
{
"DOI": "10.1001/jama.2020.5394",
"article-title": "Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region",
"author": "Grasselli",
"doi-asserted-by": "crossref",
"first-page": "1574",
"journal-title": "Italy. JAMA",
"key": "10.1016/j.ijantimicag.2020.106249_bib0008",
"volume": "323",
"year": "2020"
},
{
"DOI": "10.1056/NEJMoa2002032",
"article-title": "Clinical characteristics of coronavirus disease 2019 in China",
"author": "Guan",
"doi-asserted-by": "crossref",
"first-page": "1708",
"journal-title": "N Engl J Med",
"key": "10.1016/j.ijantimicag.2020.106249_bib0009",
"volume": "382",
"year": "2020"
},
{
"DOI": "10.1111/anae.15201",
"article-title": "Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies",
"author": "Armstrong",
"doi-asserted-by": "crossref",
"first-page": "1340",
"journal-title": "Anaesthesia",
"key": "10.1016/j.ijantimicag.2020.106249_bib0010",
"volume": "75",
"year": "2020"
},
{
"DOI": "10.1056/NEJMoa2001282",
"article-title": "A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19",
"author": "Cao",
"doi-asserted-by": "crossref",
"first-page": "1787",
"journal-title": "N Engl J Med",
"key": "10.1016/j.ijantimicag.2020.106249_bib0011",
"volume": "382",
"year": "2020"
},
{
"key": "10.1016/j.ijantimicag.2020.106249_bib0012",
"unstructured": "Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine, 5 June 2020. https://www.recoverytrial.net/files/hcq-recovery-statement-050620-final-002.pdf [accessed 3 December 2020]."
}
],
"reference-count": 12,
"references-count": 12,
"relation": {},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S0924857920304696"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Pharmacology (medical)",
"Infectious Diseases",
"Microbiology (medical)",
"General Medicine"
],
"subtitle": [],
"title": "COVID-19 in hospitalised patients in Spain: a cohort study in Madrid",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
"volume": "57"
}
